Drug intelligence / Profile preview

diosgenin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Diosgenin is a **natural steroidal sapogenin** phytochemical found primarily in yams (*Dioscorea* species) and some other plants. It is **used as a starting material for the commercial synthesis of steroid hormones** such as cortisone, pregnenolone, and progesterone[7][3][1]. Diosgenin exhibits a wide range of **biological activities** in preclinical studies, including anti-cancer, anti-inflammatory, anti-thrombotic, anti-hyperlipidemic, immunomodulatory, antioxidant, and anti-diabetic effects[3][1]. It has been used as a research tool for the investigation of mechanisms in cancer, cardiovascular disease, diabetes, neuroprotection, osteoporosis, and skin disorders[3][1]. While multiple preclinical and some early clinical studies show promise and report diosgenin's **non-toxic nature and diverse pharmacological actions**, there is no established pharmaceutical application for diosgenin itself as a therapeutic; rather, it is crucial as a precursor for the industrial synthesis of steroid drugs[1][7][3]. Its mechanisms of action are suggested to involve **inhibition of cancer cell proliferation, induction of apoptosis, anti-inflammatory pathways, and modulation of immune responses**[1][3].

Other names
SAPOGENINdiosgenDIOSGENIN (3B-HYDROXY-5A-SPIROSCENE)6-Keto Diosgenin3β-Hydroxy-5-spirosteneSP 37SP37SP-37DiosgDiosgemom22alpha-Spirost-5-en-3beta-ol25d-Spirost-5-en-3b-ol5-22-Spirosten-3-ol5-25D-Spirosten-3-oldelta 5,20a,22a,25D-spirosten-3beta-olNitogenin(3beta,25R)-spirost-5-en-3-ol3A-Hydroxy-5-spirostene(25R)-5-Spirosten-3A-ol(3|A,25R)-Spirost-5-en-3-olC08898C-08898C 08898
02

Targets

MDM2 (Mouse double minute 2 homolog)IGF-1R (Insulin-like growth factor 1 receptor)Mechanistic target of rapamycin complex 1SLC1A5 (Alanine/serine/cysteine transporter 2)EGFR T790M (Epidermal growth factor receptor T790M mutant)FGFR1 (Fibroblast growth factor receptor 1)VEGFR (VEGFR family)

Beyond the preview

Go deeper on diosgenin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diosgenin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call